Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000631797 | SCV000752889 | likely benign | Long QT syndrome | 2023-02-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002360510 | SCV002657488 | likely benign | Cardiovascular phenotype | 2019-02-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002499042 | SCV002809330 | likely benign | Long QT syndrome 13; Familial hyperaldosteronism type III | 2022-04-14 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004705730 | SCV005211314 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003935757 | SCV004748066 | likely benign | KCNJ5-related disorder | 2019-06-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |